Combined metformin and insulin therapy improves neurocognitive dysfunction in type 2 diabetic rat model via anti-inflammatory and antioxidant mechanisms
Physiology and Pharmacology · 2024
DOI: 10.61186/phypha.28.2.141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiology and Pharmacology, 2024. Verfasst von Heba Rady Salem und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Salem, H. R., Hanna, G. S., Hassan, M. H., El-kotb, S., Rashad, S., Yassien, R. I., Selim, M., & Amer, G. S. (2024). Combined metformin and insulin therapy improves neurocognitive dysfunction in type 2 diabetic rat model via anti-inflammatory and antioxidant mechanisms. Physiology and Pharmacology. https://doi.org/10.61186/phypha.28.2.141
Vancouver
Salem HR, Hanna GS, Hassan MH, El-kotb S, Rashad S, Yassien RI, et al. Combined metformin and insulin therapy improves neurocognitive dysfunction in type 2 diabetic rat model via anti-inflammatory and antioxidant mechanisms. Physiology and Pharmacology. 2024. doi:10.61186/phypha.28.2.141
BibTeX
@article{Salem2024,
author = {Salem, Heba Rady and Hanna, Gergess S. and Hassan, Mohammed H. and El-kotb, Safaa and Rashad, Samar and Yassien, Rania Ibrahim and Selim, Mahmoud and Amer, Ghada Samir},
title = {Combined metformin and insulin therapy improves neurocognitive dysfunction in type 2 diabetic rat model via anti-inflammatory and antioxidant mechanisms},
journal = {Physiology and Pharmacology},
year = {2024},
doi = {10.61186/phypha.28.2.141}
}
EUVIMED